Metabolic Syndrome among Adult Individuals -A Preliminary Cross Sectional Study in Kurnool District

Vinodh B Pandit, Ambekar JG, Havilah P


The adaptation of adverse lifestyle in urban and semi urban population leads to increase in prevalence of abdominal obesity, which is the basic cause for metabolic syndrome (Met S) in adults. The critical risk factors of this syndrome include type 2 diabetes mellitus (DM), cardiovascular diseases (CVD) and cancer.  According to World health report of 2002, CVD will be the largest cause of morbidity and mortality in India. The early identification of risk factors can help reduce comorbidities of this syndrome. Hence in the present study, we have under taken a preliminary cross sectional study to estimate prevalence of metabolic syndrome among adult individuals of Kurnool district, Andhra Pradesh, India. We have selected 125 male (65) and female (60) subjects aged between 20-50 years old in respect to exclusion criteria. The subjects were analyzed for metabolic syndrome using modified NECP ATP III criteria. Overall prevalence of metabolic syndrome was 29.6% where males between 31-40 years old (16.8%) were more affected than females41-50 years old (12.8%). Atherogenic lipid profile trait was highly prevalent among males and females. Most common risk factors include high triglyceride (44.8%) followed by low HDL-c (43.2%), increased waist circumference (40.8%), blood pressure (40.0%) and fasting blood glucose (29.6%). Nearly 28.8% (n=36) had at least one abnormal parameter of NECP ATP III criteria. The magnitude of metabolic syndrome was high among females than in males. Atherogenic risk factors were high among this population. Further large scale population based studies are required to carry out this district.


Atherogenic risk factors; diabetes mellitus; Kurnool; obesity; metabolic syndrome.

Full Text: PDF

Copyright (c) 2019 International Journal of Chemical and Lifesciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.